Flavio Ewerton

First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity

Sophie Postel‐Vinay, Karin H. Herbschleb, Christophe Massard et al. · European Journal of Cancer · 2019 · 104 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

First-in-human phase I dose escalation study of the Bromodomain and Extra-Terminal motif (BET) inhibitor BAY 1238097 in subjects with advanced malignancies

Sophie Postel‐Vinay, Karin H. Herbschleb, Christophe Massard et al. · European Journal of Cancer · 2016 · 15 citations

Medicine, Oncology, Pharmacology +8

Efficacy and Safety of Eliapixant in Overactive Bladder: The 12-Week, Randomised, Placebo-controlled Phase 2a OVADER Study

Flavio Ewerton, Francisco Cruz, M Kapp et al. · European Urology Focus · 2023 · 10 citations

Medicine, Pharmacology, Pharmacotherapy +10